Novartis India gets FIPB nod to sell OTC biz to GSK CPL

Last Updated: Friday, August 28, 2015, 19:32

The Foreign Investment Promotion Board (FIPB) has approved the proposal made by GSK CPL to acquire the company's OTC division, Novartis India said in a BSE filing.

Novartis flags margin increase, higher dividends, bolt-on deals

Last Updated: Thursday, June 18, 2015, 17:59

Novartis AG said on Thursday it expects to increase its profit margin this year as it restructures its drug portfolio and cuts costs, as well as generate cash for a higher dividend and smaller, strategic acquisitions.

Novartis India arm says unaware of any delisting plan

Last Updated: Thursday, June 11, 2015, 19:51

"The board of the company has not received any notice from the promoters of the company, Novartis AG, on its intention to delist the equity shares of the company from the Bombay Stock Exchange Limited," Novartis India said in a statement after trading hours.

High Court stays Rs 1.35 cr demand slapped on Novartis by NPPA

Last Updated: Monday, June 1, 2015, 17:15

Novartis, in its plea, claimed that the government by a June 14, 2013 notification had revised the price of its drug, Regestrone, used for regulating women's menstrual cycle.

Novartis India Q4 net up 2 folds at Rs 51.94 cr

Last Updated: Wednesday, May 27, 2015, 18:15

Pharmaceuticals firm Novartis India Wednesday reported over two-fold increase in standalone net at Rs 51.94 crore for the fourth quarter ended March 31, 2015.

Swiss Syngenta rejects takeover bid by US Monsanto

Last Updated: Friday, May 8, 2015, 19:08

Syngenta was formed in 2000 by the merger of Novartis Agribusiness and Zeneca Agrochemicals.

New-look GSK bets on consumer health spending

Last Updated: Wednesday, May 6, 2015, 17:06

GSK predicted on Wednesday its consumer health sales would grow at a mid-single-digit compound annual rate over the next five years, slightly ahead of overall company sales.

Ready to pay "reasonable" royalty to Novartis AG: Cipla to HC

Last Updated: Monday, April 27, 2015, 23:21

Indian pharma firm Cipla Monday suggested to the Delhi High Court that it was ready to pay "reasonable" royalty to Switzerland-based drug major Novartis AG if it is allowed to manufacture respiratory disease drug, 'Indaflo', which could serve 66,000 patients in India at a cheaper rate.

Novartis warns of currency drag on 2015 earnings

Last Updated: Thursday, April 23, 2015, 13:02

Swiss drugmaker Novartis on Thursday posted declining sales in the first quarter and cautioned that dollar strength may be a bigger-than-expected drag on full-year figures.

GSK Pharma to transfer cancer drug portfolio to Novartis arm

Last Updated: Thursday, February 12, 2015, 21:59

GlaxoSmithKline Pharmaceuticals board on Thursday approved transfer of its cancer drugs portfolio to an arm of Novartis in India in return for acquiring vaccines portfolio as part of a global deal between the two-multinational pharma giants struck last year.

Novartis Q3 net loss at Rs 1.18 crore

Last Updated: Wednesday, February 4, 2015, 20:43

Drug firm Novartis India Ltd on Wednesday reported a net loss of Rs 1.18 crore for the third quarter ended December 31, 2014.

EU puts conditions on deals involving Novartis, GSK

Last Updated: Thursday, January 29, 2015, 00:14

The European Union on Wednesday approved mega deals involving drugmakers Novartis of Switzerland and GlaxoSmithKline of Britain, provided they sell off assets in the vaccines and consumer health businesses.